Myocardial Infarction Redefined—A Consensus Document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

JACC Vol. 36, No. 3, September 2000:959–69



1. Bardales RH, Hailey LS, Xie SS, Schaefer RF, Hsu S-U. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 1996;149:821—9.

2. Buja LM. Modulation of the myocardial response to injury. Lab Invest 1998;78:1345—73.

3. Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978;73:743—9.

4. Jennings RB, Reimer KA. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 1983;68 Suppl I:I-25—36.

5. Jennings RB, Schaper J, Hill ML, Steenberger CJ, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury: changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56:262—78.

6. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86—107.

7. Mallory GK, White PD, Salcedo-Salga J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases. Am Heart J 1939;18:647—71.

8. Saraste A, Pulkki K, Kallajoki M, Hendriksen K, Parvinen M, Voipio-Pulkki L-M. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320—3.


1. Alexander JH, Sparapani RA, Mahaffey KW, et al., for the PURSUIT Investigators. Association between minor elevations of creatine-kinase-MB and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA 2000;283:347—53.

2. Antman EM, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J 1997;133:596—8.

3. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342—9.

4. Apple FS, Falahati A, Paulson PR, Miller E, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I. Clin Chem 1997;43:2047—51.

5. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999;45:18—20.

6. Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T, and creatine kinase MB. Clin Chim Acta 1999;284:151—8.

7. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241—51.

8. Collinson PO. Troponin T or troponin I or CK-MB (or none?). Eur Heart J 1998;19 Suppl N:N16—24.

9. Gerhardt W, Nordin G, Ljungdahl L. Can troponin T replace CK-MB mass as “gold standard” for acute myocardial infarction (“AMI”)? Scand J Clin Lab Invest 1999;59 Suppl 230:83—9.

10. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648—53.

11. Hamm CW, Heeschen C, Goldman B, et al., the Capture Study Investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999;340:1623—9.

12. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146—50.

13. Harrington RA, Lincoff AM, Califf RM, et al., the CAVEAT Investigators. Characteristics and consequences of myocardial infarction following percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomomy Trial (CAVEAT). J Am Coll Cardiol 1995;25:1693—9.

14. Ishikawa Y, Saffitz JE, Mealman TL, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clin Chem 1997;43:467—75.

15. Lindahl B, Venge P, Wallentin L, the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651—7.

16. Ohman EM, Armstrong PW, Christenson RH, et al., the GUSTO-IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996;335:1333—41.

17. Ottani F, Galvani M, Ferrini D, et al. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. Am Heart J 1999;137:284—91.

18. Ravkilde J, Horder M, Gerhardt W, et al. Diagnostic performance and prognostic values of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993;53:677—85.

19. Tardiff BE, Califf RM, Tcheng JE, et al., the IMPACT-II Investigators. Clinical outcomes after detection of elevated enzymes in patients undergoing percutaneous intervention: IMPACT-II trial (Integrilin [eptifibatide] to Minimize Platelet Aggregation and Coronary Thrombosis-II). J Am Coll Cardiol 1999;33:88—96.

20. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery disease. Clin Chem 1999;45:1104—21.

21. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671—7.


1. Anderson WD, Wagner NB, Lee KL, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts. Am J Cardiol 1988;61:729—33.

2. Chou T, Knilans T. Myocardial infarction: myocardial injury, and myocardial ischemia. In: Chou TC, Knilans TK, editors. Electrocardiography in Clinical Practice: Adult and Pediatric, 4th ed. Philadelphia: W.B. Saunders, 1996:121.

3. Crow RS, Prineas RJ, Jacobs DR, Blackburn H. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes. Am J Cardiol 1989;64:454—61.

4. Menown IBA, MacKenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J 2000;21:275—83.

5. Pahlm US, Chaitman BR, Rautaharju PM, Selvester RH, Wagner GS. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. Am J Cardiol 1998;81:809—15.

6. Prineas RJ, Crow RJ, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Wright J, editor. Boston: John Wright, PSG Inc, 1982:1—22imaging, epidemiology,9.

7. Rautaharju PM, Park LP, Chaitman BR, Rautaharju F, Zhang ZM. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 1998;31:157—87.

8. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size: the development and application of the system. Arch Intern Med 1985;145:1877—81.


1. Beller GA. Assessment of myocardial viability. Curr Opin Cardiol 1997;12:459—67.

2. Buda AJ. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction Circulation 1991;84 Suppl I:I-109—121.

3. Duca MD, Giri S, Wu AHB, et al. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol 1999;6:570—6.

4. Gibler WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995;25:1—8.

5. Lieberman AN, Weiss JL, Jugdutt BI, et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial function in the dog. Circulation 1981;63:739—46.

6. Machecourt J, Longere P, Fagret D, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. J Am Coll Cardiol 1994;23:1096—106.

7. Manoury C, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m sestamibi myocardial gated SPECT. J Nucl Med 1997;38:958—61.

8. Peels, C, Visser CA, Funkekupper AJ, Visser FC, Roos JP. Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room. Am J Cardiol 1990;65:687—91.

9. Sabia P, Abbott RD, Afrookteh A, Keller MW, Touchtone DA, Kaul S. Importance to two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms. Circulation 1991;84:1615—24.

10. Saeian K, Rhyne TL, Sagar KB. Ultrasonic tissue characterization for diagnosis of acute myocardial infarction in the coronary care unit. Am J Cardiol 1994;74:1211—5.

11. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patients. Ann Emerg Med 1997;29:116—25.


1. Burke GL, Edlavitch SA, Crow RS. The effects of diagnostic criteria on trends in coronary heart disease morbidity: the Minnesota Heart Survey. J Clin Epidemiol 1989;42:17—24.

2. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150—8.

3. McGovern PG, Pankow JS, Shahar E, for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease—mortality, morbidity, medical care and risk factors. N Engl J Med 1966;334:884—90.

4. Rose GA, Blackburn H. Cardiovascular survey methods. World Heart Organization, Geneva, Switzerland, 1968.

5. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583—612.

6. Weinstein BJ, Epstein FH, and the Working Subcommittee on Criteria and Methods, Committee on Epidemiological Studies, American Heart Association. Comparability of criteria and methods in the epidemiology of cardiovascular disease: report of a survey. Circulation 1964;30:643.

7. World Health Organization, Working Group on the Establishment of Ischemic Heart Disease Registers. Report of the Fifth Working Group, Copenhagen. In: Report no. Eur 8201 (5). World Health Organization, Geneva, 1971.

8. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607—9.

9. Porela P, Helenius H, Pulkki K, Voipio-Pulkki L-M. Epidemiological classification of acute myocardial infarction: time for a change? Eur Heart J 1999;20:1459—64.

© 2000 by The American College of Cardiology
Published by Elsevier Science Inc.

Copyright © 2000 American College of Cardiology

Tags: , ,

Leave a Comment